Cornerstone Therapeutics (NASDAQ:CRTX) is a specialty pharmaceutical company focused on products for hospitals and specialty markets. The company turned a profit early in its history, then went deep in the red acquiring products that fit its focus. In 2013, Cornerstone has come roaring back to profitability, and is one of the most exciting growth stories I've seen this year.
At the company's recent price of about $9.40, I see a near certain gain of at least 62% within a year, with a highly unlikely potential loss of 33%. I couldn't believe such a clearly undervalued company could be floating under our noses, until I realized just how many noses it was floating under. The Q2 2013 earnings call...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|